Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
Perzia B, Theotoka D, Li K, Moss E, Matesva M, Gill M, Kibe M, Chow J, Green S. Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak. American Journal Of Ophthalmology Case Reports 2022, 29: 101779. PMID: 36573234, PMCID: PMC9744718, DOI: 10.1016/j.ajoc.2022.101779.Peer-Reviewed Original ResearchMonkeypox virusRight eye painRight eye rednessTen-day coursePossible therapeutic approachesGlobal health emergencyWorld Health OrganizationAnal painTopical trifluridineConjunctival injectionEye painOcular examinationOcular manifestationsOphthalmic manifestationsDiffuse rashClinical presentationEye rednessClinical manifestationsSystemic symptomsEmergency departmentPustular lesionsVesicular lesionsWhite plaquesPerianal regionTherapeutic approaches